Realta Investment Advisors Buys New Holdings in Astera Labs, Inc. $ALAB

Realta Investment Advisors purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 2,370 shares of the company's stock, valued at approximately $214,000.

Other large investors also recently modified their holdings of the company. Hoey Investments Inc. raised its holdings in shares of Astera Labs by 4.2% in the 1st quarter. Hoey Investments Inc. now owns 5,000 shares of the company's stock valued at $298,000 after purchasing an additional 200 shares in the last quarter. Sound Income Strategies LLC increased its holdings in Astera Labs by 34.7% in the first quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after buying an additional 204 shares during the last quarter. Wealthcare Advisory Partners LLC raised its stake in Astera Labs by 0.8% in the second quarter. Wealthcare Advisory Partners LLC now owns 29,160 shares of the company's stock valued at $2,637,000 after buying an additional 221 shares in the last quarter. Allworth Financial LP lifted its holdings in Astera Labs by 20.4% during the 1st quarter. Allworth Financial LP now owns 1,394 shares of the company's stock worth $90,000 after buying an additional 236 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Astera Labs by 55.7% during the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after buying an additional 284 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $200.74 on Monday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The firm has a market capitalization of $33.37 billion, a price-to-earnings ratio of 358.46, a price-to-earnings-growth ratio of 5.09 and a beta of 1.43. The business's 50 day simple moving average is $189.83 and its 200-day simple moving average is $119.85.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. During the same period in the prior year, the company earned $0.13 EPS. The firm's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 152,517 shares of the stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the transaction, the chief executive officer directly owned 450,001 shares in the company, valued at approximately $76,648,670.33. This represents a 25.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the transaction, the director directly owned 385,863 shares in the company, valued at approximately $66,858,482.01. This represents a 32.17% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,492,036 shares of company stock valued at $232,607,552. Insiders own 12.50% of the company's stock.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent analyst reports. Morgan Stanley increased their price objective on Astera Labs from $155.00 to $200.00 and gave the company an "overweight" rating in a report on Friday, August 29th. Barclays reiterated an "overweight" rating and issued a $155.00 price target (up from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Needham & Company LLC boosted their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Cowen assumed coverage on shares of Astera Labs in a research report on Tuesday, September 30th. They issued a "hold" rating on the stock. Finally, Zacks Research upgraded shares of Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and seven have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $159.83.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.